Compare Nuwellis Inc (NUWE) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Paychex, Inc. — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while Paychex, Inc. trades at $104.29 (market cap $36.15B). The key difference: Paychex, Inc. is far larger — about 16431.8× Nuwellis Inc's market cap, and Paychex, Inc. pays a 4.69% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Paychex, Inc. for 56 Days on average.
| NUWE | PAYX | |
|---|---|---|
Market Cap | $2.20M | $36.15B |
Volume | 121,544 | 2,429,537 |
Sector | Health | Industrials |
52-Week High | $146.65 | $128.59 |
52-Week Low | $0.68 | $85.57 |
Typical Hold Time | 26 Days | 56 Days |
Enterprise Value | -$1.52M | $39.84B |
Dividend Yield | — | 4.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Paychex (PAYX) trades at $104.46, up 3.41% today, but remains in a bearish technical trend with resistance near $103. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.34, and maintains robust profitability with a net margin of 27.35%. Recent news highlights concerns over labor market cooling and dividend sustainability despite consistent payouts.
Outlook is mixed: solid fundamentals and a $111 consensus price target suggest upside, but bearish technicals and competitive pressures pose risks. The stock offers income via dividends, yet investor sentiment is cautious amid earnings quality questions and macroeconomic headwinds affecting small business employment trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
